+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Electrophysiology Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5028117
The global market for Electrophysiology Devices was estimated at US$10.4 Billion in 2023 and is projected to reach US$17.9 Billion by 2030, growing at a CAGR of 8.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Electrophysiology Devices Market - Key Trends and Drivers Summarized

How Are Electrophysiology Devices Enhancing Cardiac Diagnostics and Treatment?

Electrophysiology devices are transforming the landscape of cardiac care by enabling precise diagnostics and effective treatment of heart rhythm disorders. These devices, including diagnostic catheters, mapping and recording systems, and complex ablation devices, play crucial roles in identifying and managing conditions such as atrial fibrillation, flutter, and ventricular tachycardia. By providing detailed insights into the electrical activity of the heart, electrophysiology devices help pinpoint the origins of arrhythmias and guide interventions that can restore normal heart rhythm. This targeted approach improves the accuracy of treatments and can significantly enhance patient outcomes by reducing symptoms, preventing complications, and sometimes curing the underlying condition.

What Innovations Are Enhancing the Functionality of Electrophysiology Devices?

Innovations in electrophysiology devices are focused on improving the accuracy, safety, and patient outcomes of cardiac arrhythmia management. One of the key advancements includes the development of high-definition mapping systems that offer clearer and more detailed visualizations of the heart's electrical activity, enabling more precise ablations. Integration of advanced imaging technologies such as intracardiac echocardiography (ICE) with electrophysiology studies provides real-time, detailed anatomical views during procedures, enhancing safety and efficacy. Additionally, the use of robotic navigation systems allows for more precise manipulation of catheters, reducing the physical strain on physicians and potentially decreasing procedure times. Wearable technology and remote monitoring devices also represent significant advancements, extending the capabilities of electrophysiology beyond the hospital setting by continuously tracking heart function and detecting arrhythmias in real-time.

How Do Electrophysiology Devices Impact Healthcare Efficiency?

Electrophysiology devices significantly impact healthcare efficiency by enabling faster, more accurate diagnoses and by providing more effective treatments. The use of these devices often leads to a direct improvement in the management of patients with arrhythmias, reducing the need for repeated hospital visits and long-term medication use. Advanced electrophysiology technologies streamline procedures and can reduce the risks associated with invasive treatments, leading to shorter recovery times and lower complication rates. This efficiency not only improves patient throughput but also contributes to cost savings within healthcare systems. Moreover, the ability to perform complex diagnostics and treatments in outpatient settings due to these advanced devices further reduces the economic and logistical burden on tertiary care centers.

What Trends Are Driving Growth in the Electrophysiology Devices Market?

Several trends are driving growth in the electrophysiology devices market, including the increasing prevalence of cardiovascular diseases, aging populations, and technological advancements in medical devices. As global populations age, the incidence of cardiac conditions such as atrial fibrillation is rising, fueling the demand for effective diagnostic and treatment options. There is also a growing trend towards minimally invasive procedures, which have been shown to offer benefits such as reduced recovery times and lower risks of complications. This shift is increasing the adoption of sophisticated electrophysiology devices across healthcare settings. Furthermore, the integration of digital health technologies with electrophysiology, such as data analytics and machine learning, is expanding the capabilities of these devices, making procedures more efficient and improving patient management. These trends, combined with ongoing clinical research and innovations in device technology, ensure a dynamic and expanding market for electrophysiology devices, making them indispensable tools in modern cardiac care.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Electrophysiology Ablation Catheters segment, which is expected to reach US$6.6 Billion by 2030 with a CAGR of a 9.3%. The Electrophysiology Diagnostic Catheters segment is also set to grow at 7.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.9 Billion in 2023, and China, forecasted to grow at an impressive 7.6% CAGR to reach $2.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Electrophysiology Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Electrophysiology Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Electrophysiology Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Biosense Webster, Inc., Biotronik SE & Co. KG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 41 Featured):

  • Abbott Laboratories, Inc.
  • Biosense Webster, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Stereotaxis, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Electrophysiology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Global Increase in Cardiovascular Diseases Propels Demand for Electrophysiology Devices
  • Technological Innovations in Diagnostic Catheters Enhance Cardiac Mapping Accuracy
  • Integration of Artificial Intelligence in Electrophysiology for Improved Outcomes
  • Expansion of Telehealth and Remote Monitoring Solutions in Cardiac Care
  • Market Dynamics Driven by Aging Populations and Increasing Cardiac Risk Factors
  • Development of Portable and Miniaturized Devices for Ambulatory Settings
  • Rising Preferences for Drug-Free and Non-Surgical Treatment Options
  • Global Health Initiatives and Funding Boosting Access to Electrophysiology Services
  • Innovations in Leadless Pacing and Cardiac Resynchronization Therapy
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Electrophysiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Electrophysiology Laboratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Electrophysiology Laboratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Electrophysiology Laboratory Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Electrophysiology Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Electrophysiology Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Electrophysiology Ablation Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Electrophysiology Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Electrophysiology Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Electrophysiology Diagnostic Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Atrial Fibrillation (AF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Atrial Fibrillation (AF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Atrial Fibrillation (AF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Atrial Flutter (AFL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Atrial Flutter (AFL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Atrial Flutter (AFL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 28: World Electrophysiology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
JAPAN
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
CHINA
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 50: China Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 53: China Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: China 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
EUROPE
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Electrophysiology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Electrophysiology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
FRANCE
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 65: France Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 68: France Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: France Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: France 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
GERMANY
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 74: Germany Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Germany Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Germany 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
ITALY
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 80: Italy Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Italy Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Italy 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 83: UK Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 86: UK Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: UK Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: UK 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2024 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2024 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Biosense Webster, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Stereotaxis, Inc.

Table Information